Akèy › Kasinom Selil Skwamoz Ezofajyen › Kalifòni › Los Angeles
Etid klinik pou Kasinom Selil Skwamoz Ezofajyen nan Los Angeles, CA
11 etid pou Kasinom Selil Skwamoz Ezofajyen ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Ap rekriteFaz 1/2
- UCLA Hematology/Oncology - Santa Monica ( Site 4905), Los Angeles
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Ap rekriteFaz 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Ap rekriteFaz 1/2
- University of Southern California, Los Angeles
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Ap rekriteFaz 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- START Los Angeles, Los Angeles
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
Ap rekriteFaz 2
- Los Angeles Cancer Network, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- The Angeles Clinic and Research Institute, Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Ap rekriteFaz 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Ap rekriteFaz 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
Study of XB010 in Subjects With Solid Tumors
Ap rekriteFaz 1
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
Etid Kasinom Selil Skwamoz Ezofajyen nan lòt vil
- Arlington, VA14 etid
- Nashville, TN12 etid
- Houston, TX12 etid
- Baldwin Park, CA8 etid
- New York City, NY7 etid
- San Antonio, TX7 etid
- West Valley City, UT7 etid
- Santa Monica, CA6 etid
- Queens, NY6 etid
- Dallas, TX5 etid
- Orlando, FL5 etid
- Boston, MA5 etid
Lòt etid nan Los Angeles
- Kansè Poumon ki pa ti selil87 etid
- Kansè (tout kalite)74 etid
- Kansè nan tete72 etid
- Kansè kolorektal60 etid
- Kansè pwostat60 etid
- Kansè Metastatik57 etid
- Kansè ovè50 etid
- Kansè poumon45 etid
- Karsinòm selil skuamèz tèt ak kou42 etid
- Kansè pankreyas35 etid
- Melanom34 etid
- Kansè Endomèt34 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 7, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.